Monobactams and carbapenems for treatment of intraabdominal infections

Infection

Volumn 27, Issue 2, 1999, Pages 136-147

  Brismar, B ^a,c   Nord, C E ^a,b  

^a Department of Anesthesiology ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c 64 Ersity Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BIAPENEM; CARBAPENEM DERIVATIVE; CILASTATIN; IMIPENEM; MEROPENEM; MONOBACTAM DERIVATIVE; PROTEINASE INHIBITOR; THIENAMYCIN DERIVATIVE;

ABDOMEN; BACTERIAL INFECTION; CLINICAL TRIAL; HUMAN; REVIEW;

ABDOMEN; AZTREONAM; BACTERIAL INFECTIONS; CARBAPENEMS; CILASTATIN; CLINICAL TRIALS; HUMANS; IMIPENEM; MONOBACTAMS; PROTEASE INHIBITORS; THIENAMYCINS;

EID: 0033092942     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02560517     Document Type: Article

References (25)

1. Williams, R. R., Holchkin, D.: Aztreonam plus clindamycin ersus tobramycin plus clindamycin in the treatment of intraabdominal infections.Ann. Hematol. Infect. Dis. 13 (1991) S629-S633.
2. Fabian, T. C., Hess, M. M., Croce, M. A., Wilson, R. S., Wilson, S. E., Charland, S. L., Rodman, J. H., Boucher, B. A.: Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal trauma. Am. J. Surg. 167 (1994) 291-296.
3. Barboza, E., del Castillo, M., Yi, A., Goluzzo, E.: Clindamycin plus amikacin ersus clindamycin plus aztreonam in established intraabdominal infections.Surgery 116 (1994) 28-35.
4. de Lissooy, G., Elixhauscr, A., Luce, B. R., Weschler, J., Mowery, P., Reblando, J., Solontkin, J.: Cost analysis of imipenem-cilastatin ersus clindamycin with tobramycin in the treatment of acute intraabdominal infection.Pharmaco-Economics 4 (1993) 203-214.
5. Solomkin, J. S., Dcllingcr, E. P., Christou, N., Busuttil, R. W.: Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/ clindamycin for intraabdominal infections. Ann. Surg. 212 (1990) 581-591.
6. Jhee, S. S., Gill, M. A., Yellin, A. E., Berne, T. ., Heseltine, P. N., Applcman, M. D.: Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intraabdominal infections. Clin.Therapeut. 17 (1995) 126-135.
7. Poenaru, D., Santis, M. D., Christou, N. .: Imipenem ersus tobramycin - antianaerobe therapy in intraabdominal infections.Can. J. Surg. 33 (1990) 415-422.
8. Uhari, M., Seppänen, J., Heikkinen, E.: Imipenem-cilastatin ersus tobramycin-metronidazole for appendicitis-related infections. Pediatr. Infect. Dis. J. 11 (1992) 445-450.
9. Solomkin, J. S., Reinhart, H. H., Dellinger, E. P., Bohnen, J. M., Rotstein, O. D., ogel, S. B., Simms, H. H., Hill, C. S., Bjornson, H. S., Ha. Ann. Hematol. 64 ersfock, D. C, Coulter, H. O., Echols, R. M.: Results of a randomized trial comparing sequential intraenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intraabdominal infections.Ann. Surg. 223 (1996) 303-315.
10. Cakmakci, M., Stern, A., Schilling, J., Christen, D., Roggo, A., Gcroulanos, S.: Randomized comparatie trial of imipenem/cilastatin ersus aminoglycoside plus amoxycillin plus clindamycin in the treatment of seere intra- and post-operatie infections. Drugs Exptl. Clin. Res. 19 (1993) 223-227.
11. Brismar, B., Malmborg, A. S., Tuneall, G., Wretlind, B., Bergman, L., Menizing, L. O., Nyslröm, P. O., Kihlström, E., Bäckstrand, B., Skaii, T., Kasholm-Tcnge, B., Sjöberg, L., OIsson-Liljcquist, B., Tally, F. R, Galenbeck, L., Eklund, A. E., Nord, C. E.: Piperacillintazobactam ersus imipenem-cilastatin for treatment of intraabdominal infections.Antimicrob. Agents Chemother. 36 (1992) 2766-2773.
12. Niinikoski, J., Haia, T., Alhaa, E., Paakkoncn, M., Miettinen, P., Ki. Ann. Hematol. 64 ilaakso, E., Haapiainen, R., Matikainen, M., Laitinen, S.: Piperacillin/tazobactam ersus imipenem/cilastatin in the treatment of intraabdominal infections. Surg., Gynecol., Obstetr. 176 (1993) 255-261.
13. de Groot, H. G., Hustinx, P. A., Lampe, A. S., Oosterwijk, W. M.: Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intraabdominal infections. J. Antimicrob. Chemother. 32 (1993) 491-500.
14. Hall-Angerås, M., Darle, N., Hamnström, K., Ekelund, M., Engström, L.,Takala, J., . Ann. Hematol. 64 iste, A., Bendix Holme, J.: A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intraabdominal infections. Scand. J. Infect. Dis. 28 (1996) 513-518.
15. Berne, T. ., Yellin, A. E., Appleman, M. D., Heseltine,T. ., Gill, M. A.: Meropenem ersus tobramycin with clindamycin in the antibiotic management of patients with adanced appendicitis. J. Am. Coll. Surg. 182 (1996) 403-407.
16. Wilson, S. E.: Results of a randomized multicenter trial of meropenem ersus clindamycin/tobramycin for the treatment of intraabdominal infections. Clin. Infect. Dis. 24 (1997) S197-S206.
17. Pitkin, D., Sheikh, W., Wilson, S. E., Hemsell, D., Nichols, R., Nadler, H., Donzicky, M.: Comparison of the actiity of meropenem with that of other agents in the treatment of intraabdominal obstetric/gynecologic and skin and soft tissue infections. Clin. Infect. Dis. 20 (1995) S372-S375.
18. Kanellakopolou, K., Giamarcllou, H., Papadothomakos, P., Tsipras, H., Chloroyiannis, J., Theakou, R., Sfikakis, P.: Meropenem ersus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery. Eur. J. Clin. Microbiol. Infect. Dis. 12 (1993) 449-153.
19. Kenipf, P., Bauernfeind, A., Müller, A., Blum, J.: Meropenem monotherapy ersus cefotaxime plus metronidazole combination treatment for serious intraabdominal infections.Infection 24 (1996) 473-479.
20. Geroulanos, S. J., The Meropenem Study Group: Meropenem ersus imipenem/cilastatin in intraabdominal infections requiring surgery. J. Antimicrob. Chemother. 36 (1995) 191-205.
21. Condon, R. E., Walker, A. P., Sirinek, K. R., White, P. W., Fabian, T. C., Nichols, R. L., Wilson, S. E.: Meropenem ersus tobramycin plus clindamycin for treatment of intraabdominal infections: Results of a prospectie randomized double-blind clinical trial. Clin. Infect. Dis.21 (1995) 544-550.
22. Huizinga, W. K., Warren, B. L., Baker, L. W., . Ann. Hematol. 64 alleur, P., Pezet, D. M., Hoogkamp-Korslanje, J. A. A., Karran, S. J.: Antibiotic monotherapy with meropenem in the surgical management of intraabdominal infections.J. Antimicrob. Chemother. 36 (1995) 179-189.
23. Brismar, B., Eklund, A. E., Nord, C. E.: Immune response in patients with intraabdominal infections treated with carbapenems. Int. J. Clin. Phaim Res. 14 (1994) 111-114.
24. Brismar, B., Malmborg, A. S., Tuneall, G., Lindgren, Y., Bergman, L., Mentzing, L. O., Nystrum, P. O., Ånséhn, S., Bäckstrand, B., Skau, T., Andåker, L., Gustafsson, P. O., Kasholm-Tenge, B., Sjöberg, L., Olsson-I.iljcqiiist, B., Eklund, A. E., Nord, C. E.: Meropenem ersus imipenem/cilastatin in the treatment of intraabdominal infections. J. Antimicrob. Chemother. 35 (1995) 139-148.
25. Brismar, B., Akcrlund, J.-E., Sjöstcdt, S., Johansson, C., Törnqist, A., Bäckstrand, B., Bång, H., Andåker, L., Gustafsson, P.-O., Darle, N., Angerås, M., Falk, A., Tuneall, G., Kasholm-Tcnge, B., Skau, T., Nyström, P.-O., Gasslander, T., Hagclbäck, A., OIsson-Liljequisl, B., Eklund, A.-E., Nord, C. E.: Biapenem ersus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: Report from a Swedish Study Group.Scand. J. Infect. Dis. 28 (1996) 507-512.